期刊文献+

卡托普利联合厄贝沙坦片治疗老年高血压疗效观察 被引量:1

Effect of captopril combined with irbesartan in treatment on elderly patients with hypertension
下载PDF
导出
摘要 目的探讨卡托普利联合厄贝沙坦片治疗老年高血压的临床效果。方法 126例老年高血压患者分为观察组64例和对照组62例,对照组患者给予厄贝沙坦片治疗,观察组患者给予卡托普利联合厄贝沙坦片治疗,观察2组患者治疗前后血压变化,并对2组患者生活质量进行比较。结果治疗前2组患者收缩压(SBP)、舒张压(DBP)水平比较差异无统计学意义(P>0.05);2组患者治疗后SBP、DBP水平均显著低于治疗前,差异有统计学意义(P<0.05)。治疗后观察组SBP、DBP水平显著低于对照组,差异有统计学意义(P<0.05)。治疗前2组患者生活质量比较差异无统计学意义(P>0.05);与治疗前比较,2组患者治疗后生活质量均显著改善,差异有统计学意义(P<0.05);治疗后观察组患者生活质量改善显著优于对照组,差异有统计学意义(P<0.05)。2组患者不良反应发生率比较差异无统计学意义(P>0.05)。结论卡托普利联合厄贝沙坦治疗老年高血压疗效确切,且能够提高患者生活质量。 Objective To explore the effect of captopril combined with irbesartan in treatment of elderly patients with hypertension.Methods A total of 126 elderly patients with hypertension were divided into observation group(n = 64) and control group(n = 62).The patients in control group were treated with irbesartan tablet,while the patients in observation group were treated with captopril and irbesartan tablet.Changes of blood pressure were observed in the two groups,and the quality of life was compared between the two groups.Results There was no significant difference in systolic blood pressure(SBP) and diastolic blood pressure(DBP) between the two groups before treatment(P 〉0.05).The levels of SBP and DBP after treatment were significantly lower than those before treatment in the two groups(P 〈0.05).The levels of SBP and DBP in observation group were significantly lower than those in control group after treatment(P 〈0.05).There was no significant difference in the quality of life between the two groups before treatment(P 〉0.05).The improvement of the quality of life after treatment were significantly more than that before treatment in the two groups(P 〈0.05).The improvement of the quality of life in observation group was significantly more than that in control group after treatment(P 〈0.05).There was no significant difference in the adverse reaction rate between the two groups(P〉0.05).Conclusion Captopril combined with irbesartan for treating hypertension in elderly patients can obtain certain effect,and can improve the quality of life.
作者 邵炀 曹佳宁
出处 《新乡医学院学报》 CAS 2014年第7期566-568,共3页 Journal of Xinxiang Medical University
关键词 卡托普利 厄贝沙坦片 高血压 captopril irbesartan hypertension
  • 相关文献

参考文献5

  • 1李国辉.厄贝沙坦治疗老年原发性高血压的疗效观察[J].新乡医学院学报,2012,29(2):127-128. 被引量:4
  • 2王晓明,丁铭格,张航向.老年高血压诊疗的思考及治疗对策[J].中华老年心脑血管病杂志,2013,15(3):225-227. 被引量:22
  • 3Corey E. Tabit,William B. Chung,Naomi M. Hamburg,Joseph A. Vita.Endothelial dysfunction in diabetes mellitus: Molecular mechanisms and clinical implications[J].Reviews in Endocrine and Metabolic Disorders.2010(1) 被引量:1
  • 4Peter John Wormald.The agger nasi cell: the key to understanding the anatomy of the frontal recess[J].Otolaryngology - Head and Neck Surgery.2003(5) 被引量:1
  • 5M.Akram Khan,Connie S Combs,Elizabeth M Brunt,Val J Lowe,Michael K Wolverson,Harvey Solomon,Brian T Collins,Adrian M.Di Bisceglie.Positron emission tomography scanning in the evaluation of hepatocellular carcinoma[J].Journal of Hepatology.2000(5) 被引量:1

二级参考文献18

  • 1Persson I A, Persson K, Hagg S, et al. Effects of cocoa extract and dark chocolate on angiotensin-converting enzyme and nitric oxide in human endothelial cells and healthy volunteers:a nutrigenomics perspective [ J ]. J Cardiovasc Pharmacol,2011,57 ( 1 ) :44-50. 被引量:1
  • 2Aronow WS,Fleg JL,Pepine CJ,et al. ACCF/AHA 2011 ex . pert consensus document on hypertension in the elderly:a re- port of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents developed in collaboration with the American Academy of Neurology, A merican Geriatrics Society, American Society for Preventive Cardiology,American Society of Hypertension, American So ciety of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Soc Hypertens, 2011,5:259 352. 被引量:1
  • 3Wang JG, Staessen JA, Gong L, et al. Chinese trial on isolated systolic hypertension in the elderly. Systolic Hypertension in China (SysbChina) Collaborative Group. Arch Intern Meal, 2000,160 : 211-220. 被引量:1
  • 4Beckett NS,Peters R,Fletcher AE,et al. Treatment of hyper- tension in patients 80 years of age or older. N Engl J Med, 2008,358 : 1887-1898. 被引量:1
  • 5JATOS Study Group. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res, 2008,31 : 2115-2127. 被引量:1
  • 6Bejan-Angoulvant T, Saadatian-Elahi M, Wright JM, et al. Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomized controlled trials. J Hypertens, 2010,28 : 1366- 1372. 被引量:1
  • 7Ogihara T, Saruta T, Rakugi H, et al. Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension study. Hy- pertension,2010,56 : 196- 202. 被引量:1
  • 8McDonald M, Hertz RP, Unger AN, et al. Prevalence, aware- ness, and management of hypertension, dyslipidemia, and dia- betes among United States adults aged 65 and older. J Geron- tol A BiolSci Med Sci,2009,64:256-263. 被引量:1
  • 9Zhang Y,Zhang X,Liu L,et al. Effects of individual risk fac- tors on the residual risk of cardiovascular events in a popula- tion of treated Chinese patients with hypertension:data from the felodipine event reduction (FEVER) study. Hyperten sion, 2010,28:2016-2025. 被引量:1
  • 10彭振华,李世勋,秦莉花,李晟,石瑞正.不同降压药物对原发性高血压患者心率变异性的影响[J].新乡医学院学报,2010,27(2):178-181. 被引量:6

共引文献24

同被引文献14

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部